Food Consumption In Male Rats Research Articles

Eating Habits Associated with Overweight and Obesity: Case - Control Study in 11-14 year old Adolescents in Hanoi in 2020

Eating Habits Associated with Overweight and Obesity: Case - Control Study in 11-14 year old Adolescents in Hanoi in 2020

Carbon dioxide in carbonated beverages induces ghrelin release and increased food consumption in male rats: Implications on the onset of obesity

The dangerous health risks associated with obesity makes it a very serious public health issue. Numerous studies verified a correlation between the increase in obesity and the parallel increase in soft drink consumption among world populations. The effects of one main component in soft drinks namely the carbon dioxide gas has not been studied thoroughly in any previous research. Male rats were subjected to different categories of drinks and evaluated for over a year. Stomach ex vivo experiments were undertaken to evaluate the amount of ghrelin upon different beverage treatments. Moreover, 20 male students were tested for their ghrelin levels after ingestion of different beverages. Here, we show that rats consuming gaseous beverages over a period of around 1 year gain weight at a faster rate than controls on regular degassed carbonated beverage or tap water. This is due to elevated levels of the hunger hormone ghrelin and thus greater food intake in rats drinking carbonated drinks compared to control rats. Moreover, an increase in liver lipid accumulation of rats treated with gaseous drinks is shown opposed to control rats treated with degassed beverage or tap water. In a parallel study, the levels of ghrelin hormone were increased in 20 healthy human males upon drinking carbonated beverages compared to controls. These results implicate a major role for carbon dioxide gas in soft drinks in inducing weight gain and the onset of obesity via ghrelin release and stimulation of the hunger response in male mammals.

Possible Involvement of Beta-Adrenergic Receptors on Nociceptin/Orphanin FQ Induced Food Consumption in Male Rats

Background: The nociceptin/orphanin FQ (N/OFQ) peptide is the endogenous ligand for the N/OFQ peptide (NOP) receptor. Beta adrenergic receptors and N/OFQ are involved in the regulation of food intake through central and peripheral mechanisms. Objectives: The aim of this study was to determine the possible interaction between beta adrenergic and N/OFQ receptors on food consumption in male rats. N/OFQ agonists have been shown to increase food intake in mammals and birds. Beta adrenergic receptors physiologically inhibit food intake in mammals. Methods: In this experimental study were used male rats (250-300 g). In first two experiments, rats received intraperitoneal injections of isoproterenol (0, 0.5, 1 and 2 mg/kg) and Nociceptin agonist 64 - 6198 (0, 1, 2 and 4 mg/kg) respectively. In third experiment 64 - 6198 (4 mg/kg) and (2 mg/kg) isoproterenol were injected. In experiments 4 effects of isoproterenol (0.5 mg/kg) and Nociceptin antagonist (8 mg/kg) on food consumption was investigated. Latency time to feeding was examined in experiment 5. The data were statistically analyzed using One-way ANOVA and Tukey test. Results: Latency time to feeding increased and decreased by isoproterenol and nociceptin/orphanin, respectively. Administration of N/OFQ increased cumulative food intake in rats (P < 0.05). The i.p. injection of isoproterenol decreased food intake and also the hyperphagic effect of N/OFQ agonist is inhibited by isoproterenol, whereas sub-anorectic doses of isoproterenol and N/OFQ antagonist synergistically attenuated cumulative feed consumption when combined (P < 0.01). Conclusions: On the basis of these findings, it can be concluded that isoproterenol may decrease food intake in rats by reduction in the N/OFQ content.

The effects of intracerebroventricular injection of ascorbic acid on feeding behavior in male rats

research has shown that the release of these two neurotransmitters from their relevant neurons is involved in the central ascorbic acid (AA) release, and the released ascorbic acid can modulate their effects. In the present study, we evaluated the effects of intracerebroventricular injection of ascorbic acid on food consumption in male rats at light phase. Materials and Methods: For this purpose, 50 NMRI rats weighing about 250-300 g were selected randomly and divided into 5 equal groups including control, sham (ascorbic acid solvent), and 25, 50 and 100 µg/10 µl ascorbic acid. First, the animals were annulated (within the right ventricle of the brain). Seven days after the recovery period, all the drugs were injected into the right brain ventricle, after 12 h of food deprivation. Then, the animals were put in the metabolic cages equipped with computer software and the number of container reference and food intake was measured. The amounts of food consumption every 60 minutes and for about 4 hours after injection were recorded. Results: The findings showed that intracerebroventricular administration of ascorbic acid decreased food intake at all three doses, which were important in dosage of 25 µg (P< 0.05). Also, the number of container reference was reduced in ascorbic acid groups compared to the control group. All three doses of ascorbic acid also reduced food intake. This reduction was significant only in the 100 µg ascorbic acid group (P<0.05).

Subchronic Feeding Study of N,N-Dimethylformamide in Rats and Mice

Wistar rats (25/ sex • group) and CD-1 mice (30/sex • group) were fed either a control diet or diet supplemented with N,N-dimethylformamide at the levels of 215, 750, and 2500 ppm for rats and 160,540, and 1850 ppm for mice. The duration of feeding was 104 days for rats and 119 days for mice. Body weight gain, food consumption, hematological and clinical chemical data, ophthalmic, gross, and microscopic examinations were used to study possible toxic or pathologic effects. A significant reduction in body weight gain was noted for male and female rats at the high dosage level. Food consumption in male rats at the high-dosage level and female rats at both the middle- and high-dosage levels was decreased. A significant dose-related increase in relative liver weights was noted in male and female rats. Absolute liver weights of male rats were comparable among groups, however, a dose-related increase was noted in female rats. No significant differences among groups were noted in body weight and food consumption data for mice. A significant dose-related increase in relative and absolute liver weights was noted in male and female mice. Histopathological evaluation revealed no evidence of a toxic effect related to feeding of N.N-dimethylformamide to Wistar rats and CD-1 mice. The increase in liver weight is considered to be a normal phenomenon (physiological adaptation) required for the biotransformation of N,N-dimethylformamide. The lack of hepatotoxicity in the present study may be the result of feeding N,N-dimethylf ormamide over waking hours versus bolus dosing (in other studies) in which hepatotoxicity was noted.